Cargando…

Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy

AIMS: Left atrial (LA) function is a marker of prognosis in patients with heart failure. The prognostic implications of an improvement in LA function in addition to an improvement in left ventricular (LV) function after cardiac resynchronization therapy (CRT) implantation are unknown. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Stassen, Jan, Galloo, Xavier, Chimed, Surenjav, Hirasawa, Kensuke, Marsan, Nina Ajmone, Delgado, Victoria, van der Bijl, Pieter, Bax, Jeroen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291382/
https://www.ncbi.nlm.nih.gov/pubmed/35213709
http://dx.doi.org/10.1093/ehjci/jeac042
_version_ 1784749127341441024
author Stassen, Jan
Galloo, Xavier
Chimed, Surenjav
Hirasawa, Kensuke
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J
author_facet Stassen, Jan
Galloo, Xavier
Chimed, Surenjav
Hirasawa, Kensuke
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J
author_sort Stassen, Jan
collection PubMed
description AIMS: Left atrial (LA) function is a marker of prognosis in patients with heart failure. The prognostic implications of an improvement in LA function in addition to an improvement in left ventricular (LV) function after cardiac resynchronization therapy (CRT) implantation are unknown. This study aimed to evaluate the prognostic value of a significant change in LA reservoir strain (RS) and/or LV global longitudinal strain (GLS) after initiation of CRT. METHODS AND RESULTS: LARS and LVGLS were measured with speckle-tracking echocardiography. Significant improvement in LARS and LVGLS was defined as a percentage change of +5% and +20% at 6 months after CRT implantation, respectively. Patients were divided into three groups: no significant reverse remodelling (no improvement in LARS and LVGLS), incomplete reverse remodelling (improvement in LARS or LVGLS), and complete reverse remodelling (improvement in LARS and LVGLS). The primary endpoint was all-cause mortality. A total of 923 patients (mean age 65 ± 10 years, 77% male) were included, of which 221 (24%) had complete reverse remodelling, 414 (45%) incomplete reverse remodelling, and 288 (31%) no significant reverse remodelling. Five-years’ mortality was 24%, 29%, and 36% for patients with complete, incomplete, and no significant reverse remodelling, respectively (P < 0.001). On multivariable analysis, complete reverse remodelling (hazard ratio 0.477; 95% confidence interval: 0.362–0.628; P < 0.001) was associated with the lowest risk of mortality. CONCLUSIONS: Patients with complete reverse remodelling have a lower mortality risk than those showing incomplete or no significant reverse remodelling. The use of integrated LA and LV deformation imaging may improve risk-stratification of CRT recipients.
format Online
Article
Text
id pubmed-9291382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92913822022-07-18 Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy Stassen, Jan Galloo, Xavier Chimed, Surenjav Hirasawa, Kensuke Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J Eur Heart J Cardiovasc Imaging Original Paper AIMS: Left atrial (LA) function is a marker of prognosis in patients with heart failure. The prognostic implications of an improvement in LA function in addition to an improvement in left ventricular (LV) function after cardiac resynchronization therapy (CRT) implantation are unknown. This study aimed to evaluate the prognostic value of a significant change in LA reservoir strain (RS) and/or LV global longitudinal strain (GLS) after initiation of CRT. METHODS AND RESULTS: LARS and LVGLS were measured with speckle-tracking echocardiography. Significant improvement in LARS and LVGLS was defined as a percentage change of +5% and +20% at 6 months after CRT implantation, respectively. Patients were divided into three groups: no significant reverse remodelling (no improvement in LARS and LVGLS), incomplete reverse remodelling (improvement in LARS or LVGLS), and complete reverse remodelling (improvement in LARS and LVGLS). The primary endpoint was all-cause mortality. A total of 923 patients (mean age 65 ± 10 years, 77% male) were included, of which 221 (24%) had complete reverse remodelling, 414 (45%) incomplete reverse remodelling, and 288 (31%) no significant reverse remodelling. Five-years’ mortality was 24%, 29%, and 36% for patients with complete, incomplete, and no significant reverse remodelling, respectively (P < 0.001). On multivariable analysis, complete reverse remodelling (hazard ratio 0.477; 95% confidence interval: 0.362–0.628; P < 0.001) was associated with the lowest risk of mortality. CONCLUSIONS: Patients with complete reverse remodelling have a lower mortality risk than those showing incomplete or no significant reverse remodelling. The use of integrated LA and LV deformation imaging may improve risk-stratification of CRT recipients. Oxford University Press 2022-02-25 /pmc/articles/PMC9291382/ /pubmed/35213709 http://dx.doi.org/10.1093/ehjci/jeac042 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Stassen, Jan
Galloo, Xavier
Chimed, Surenjav
Hirasawa, Kensuke
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J
Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title_full Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title_fullStr Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title_full_unstemmed Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title_short Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
title_sort clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291382/
https://www.ncbi.nlm.nih.gov/pubmed/35213709
http://dx.doi.org/10.1093/ehjci/jeac042
work_keys_str_mv AT stassenjan clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT gallooxavier clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT chimedsurenjav clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT hirasawakensuke clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT marsanninaajmone clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT delgadovictoria clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT vanderbijlpieter clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy
AT baxjeroenj clinicalimplicationsofleftatrialreverseremodellingaftercardiacresynchronizationtherapy